Active Shortage Injection Analgesia/Addiction
Sufentanil Citrate Injection · 1,592 days since initial FDA posting
Brand: SUFENTANIL CITRATE
FDA lists Sufentanil Citrate Injection as Active Shortage (Hospira, Inc., a Pfizer Company).
Availability on file: Available
Sufentanil Citrate Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Sufentanil Citrate Injection
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Dosage Form
- Injection
- Presentation
- Sufentanil Citrate, Injection, 50 ug/1 mL (NDC 0409-3382-21)
- Package NDC
- 0409-3382-21
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- May 3, 2022
- Last Updated
- Mar 13, 2026
- Therapeutic Category
- Analgesia/Addiction, Pediatric
Row fields from the FDA Drug Shortages database via openFDA.